Back to Crohns Disease And Colitis
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01316601

NCT01316601
Completed Phase 2

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Crohn's disease for more than 6 months and have a fistula (an abnormal tunnel or opening that forms between body parts)
  • You have tried at least one treatment for your fistula in the past that did not work

Who may not be able to join:

  • You have previously tried a type of medication called a TNF-alpha antibody (such as infliximab or adalimumab) and it did not work for you
  • You are already scheduled to have surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 2
Sponsor
Gerhard Rogler
Registry
clinicaltrials_gov
Start date
1 January 2011
Est. completion
1 November 2012

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

complete closure of fistula

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov